Baxter International Inc. Press Releases

BAX 
$38.09
*  
0.39
1.03%
Get BAX Alerts
*Delayed - data as of Jul. 28, 2015  -  Find a broker to begin trading BAX now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    BAX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Baxter International Second Quarter 2015 Financial Results Conference Call
7/8/2015 4:15:00 PM - Business Wire
▲4.36 % Price Change since this news event. The Volume Ratio is 0.58.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Baxter Announces Early Results of Debt Tender Offers
7/2/2015 8:00:00 AM - Business Wire
▼-1.83 % Price Change since this news event. The Volume Ratio is 1.87.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Baxter Announces Pricing of Debt Tender Offers
7/1/2015 4:46:00 PM - Business Wire
▼-1.98 % Price Change since this news event. The Volume Ratio is 1.79.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day














Baxalta Announces Pricing of $5 Billion Private Placement Notes Offering
6/19/2015 8:00:00 AM - Business Wire
▼-45.00 % Price Change since this news event. The Volume Ratio is 1.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Baxter Announces Debt Tender Offers
6/18/2015 8:30:00 AM - Business Wire
▼-44.11 % Price Change since this news event. The Volume Ratio is 0.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Baxter’s Commitment to Innovative Programs and Advancing Its Sustainability Priorities Featured in Sixteenth Report
6/10/2015 9:00:00 AM - Business Wire
▼-41.08 % Price Change since this news event. The Volume Ratio is 2.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Baxter Announces Effectiveness of Baxalta Form 10 Registration Statement
6/9/2015 5:00:00 PM - Business Wire
▼-40.56 % Price Change since this news event. The Volume Ratio is 1.96.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Baxter’s Board of Directors Approves Separation of Baxalta and Declares Special Dividend of Baxalta Stock
6/5/2015 4:30:00 PM - Business Wire
▼-41.44 % Price Change since this news event. The Volume Ratio is 0.75.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation
6/1/2015 9:00:00 AM - PR Newswire
▼-42.82 % Price Change since this news event. The Volume Ratio is 1.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Baxter Presents Data Demonstrating Remote Technology May Help Reduce Barriers to Home Therapy
5/29/2015 7:00:00 AM - Business Wire
▼-43.83 % Price Change since this news event. The Volume Ratio is 1.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Baxter and Baxalta Executives to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
5/28/2015 4:15:00 PM - Business Wire
▼-43.28 % Price Change since this news event. The Volume Ratio is 1.4.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Baxter BioScience Files for European Approval of Investigational 20% Subcutaneous Immune Globulin Treatment for Primary Immunodeficiency
5/21/2015 9:00:00 AM - Business Wire
▼-43.94 % Price Change since this news event. The Volume Ratio is 1.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Baxter and Baxalta Highlight Business Strategies at Investor Conferences
5/18/2015 8:30:00 AM - Business Wire
▼-45.08 % Price Change since this news event. The Volume Ratio is 3.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Baxter Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain, Facility for the U.S. Market
5/15/2015 5:26:00 PM - Business Wire
▼-45.08 % Price Change since this news event. The Volume Ratio is 3.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day